Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Identification of plasmalogens in Bifidobacterium longum, but not in Bifidobacterium animalis.

Mawatari S, Sasuga Y, Morisaki T, Okubo M, Emura T, Fujino T.

Sci Rep. 2020 Jan 16;10(1):427. doi: 10.1038/s41598-019-57309-7.

2.

Viral and host factors are associated with retreatment failure in hepatitis C patients receiving all-oral direct antiviral therapy.

Mawatari S, Oda K, Kumagai K, Tabu K, Ijuin S, Fujisaki K, Inada Y, Uto H, Saisyoji A, Hiramine Y, Hori T, Taniyama O, Toyodome A, Sakae H, Hashiguchi M, Kure T, Sakurai K, Tamai T, Moriuchi A, Ido A.

Hepatol Res. 2019 Dec 17. doi: 10.1111/hepr.13474. [Epub ahead of print]

PMID:
31846553
3.

Nonalcoholic fatty liver disease is associated with both subcutaneous and visceral adiposity: A cross-sectional study.

Kure T, Mawatari S, Imamura Y, Oda K, Kumagai K, Hiramine Y, Miyahara H, Kanmura S, Moriuchi A, Uto H, Horiuchi M, Ido A.

Medicine (Baltimore). 2019 Nov;98(46):e17879. doi: 10.1097/MD.0000000000017879.

4.

Extract of Lactobacillus plantarum strain 06CC2 induces JNK/p38 MAPK pathway-mediated apoptosis through endoplasmic reticulum stress in Caco2 colorectal cancer cells.

Hiraishi N, Kanmura S, Oda K, Arima S, Kumagai K, Mawatari S, Tanoue S, Sasaki F, Hashimoto S, Ido A.

Biochem Biophys Rep. 2019 Oct 3;20:100691. doi: 10.1016/j.bbrep.2019.100691. eCollection 2019 Dec.

5.

Effect of tolvaptan on the prognosis of patients with hepatic ascites.

Hiramine Y, Uto H, Mawatari S, Kanmura S, Imamura Y, Hiwaki T, Saishoji A, Yada T, Inada Y, Sakamoto H, Higashi H, Kubozono O, Maenohara S, Ido A.

Hepatol Res. 2019 Jul;49(7):765-777. doi: 10.1111/hepr.13337. Epub 2019 Apr 30.

PMID:
30916842
6.

Predictors of hepatocellular carcinoma recurrence associated with the use of direct-acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study.

Nakano M, Koga H, Ide T, Kuromatsu R, Hashimoto S, Yatsuhashi H, Seike M, Higuchi N, Nakamuta M, Shakado S, Sakisaka S, Miuma S, Nakao K, Yoshimaru Y, Sasaki Y, Oeda S, Eguchi Y, Honma Y, Harada M, Nagata K, Mawatari S, Ido A, Maeshiro T, Matsumoto S, Takami Y, Sohda T, Torimura T.

Cancer Med. 2019 May;8(5):2646-2653. doi: 10.1002/cam4.2061. Epub 2019 Mar 22.

7.

Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study.

Ide T, Koga H, Nakano M, Hashimoto S, Yatsuhashi H, Higuchi N, Nakamuta M, Oeda S, Eguchi Y, Shakado S, Sakisaka S, Yoshimaru Y, Sasaki Y, Honma Y, Harada M, Seike M, Maeshiro T, Miuma S, Nakao K, Mawatari S, Ido A, Nagata K, Matsumoto S, Takami Y, Sohda T, Kakuma T, Torimura T.

Hepatol Int. 2019 May;13(3):293-301. doi: 10.1007/s12072-019-09939-2. Epub 2019 Feb 28.

PMID:
30820753
8.

Hepatocyte Growth Factor Facilitates Esophageal Mucosal Repair and Inhibits the Submucosal Fibrosis in a Rat Model of Esophageal Ulcer.

Komaki Y, Kanmura S, Sasaki F, Maeda H, Oda K, Arima S, Tanoue S, Nasu Y, Hashimoto S, Mawatari S, Tsubouchi H, Ido A.

Digestion. 2019;99(3):227-238. doi: 10.1159/000491876. Epub 2018 Sep 18.

PMID:
30227416
9.

Sustained virologic response after eight weeks of treatment with sofosbuvir, ledipasvir, and ribavirin in a decompensated cirrhotic patient with hepatitis C virus genotype 1b.

Taniyama O, Mawatari S, Oda K, Tabu K, Ijuin S, Kumagai K, Kasai A, Tashima S, Tamai T, Moriuchi A, Ido A.

Hepatol Res. 2019 Feb;49(2):239-243. doi: 10.1111/hepr.13235. Epub 2018 Aug 26.

PMID:
30048035
10.

The co-existence of NS5A and NS5B resistance-associated substitutions is associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir.

Mawatari S, Oda K, Tabu K, Ijuin S, Kumagai K, Fujisaki K, Hashiguchi M, Inada Y, Uto H, Hiramine Y, Kure T, Hori T, Taniyama O, Kasai A, Tamai T, Moriuchi A, Ido A.

PLoS One. 2018 Jun 1;13(6):e0198642. doi: 10.1371/journal.pone.0198642. eCollection 2018.

11.

Enzymatic measurement of ether phospholipids in human plasma after hydrolysis of plasma with phospholipase A1.

Mawatari S, Hazeyama S, Morisaki T, Fujino T.

Pract Lab Med. 2018 Jan 9;10:44-51. doi: 10.1016/j.plabm.2018.01.003. eCollection 2018 Mar.

12.

Early sorafenib induction after transarterial chemoembolization for unresectable hepatocellular carcinoma: Can sorafenib after TACE improve loco-regional control?

Tamai T, Kumagai K, Sakae H, Onishi H, Tabu K, Tabu E, Muromachi K, Saishoji A, Oda K, Mawatari S, Moriuchi A, Sakurai K, Ido A.

Mol Clin Oncol. 2017 Dec;7(6):1135-1141. doi: 10.3892/mco.2017.1434. Epub 2017 Oct 2.

13.

[A Proposal for Evaluating the Positional Accuracy of Add-on Six-degrees-of-freedom Radiotherapy Couch in Couch Rotation for Image-guided Radiotherapy].

Mawatari S, Kiyao Y, Oku Y, Toyota M, Saigo Y.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(12):1231-1237. doi: 10.6009/jjrt.2017_JSRT_73.12.1231. Japanese.

14.

The recovery of the PT-INR to less than 1.3 predicts survival in patients with severe acute liver injury.

Mawatari S, Moriuchi A, Ohba F, Kawano T, Oda K, Takikawa Y, Takikawa H, Ido A, Tsubouchi H.

J Gastroenterol. 2018 Jul;53(7):861-872. doi: 10.1007/s00535-017-1421-3. Epub 2017 Dec 19.

PMID:
29260300
15.

Reduction effect of the quantity of radiation exposure and contrast media by image support system in transarterial chemoembolization for the treatment of hepatocellular carcinoma.

Tamai T, Taniyama O, Oda K, Kasai A, Ijyuin S, Sakae H, Onishi H, Tabu K, Kumagai K, Mawatari S, Moriuchi A, Uto H, Ido A.

J Gastroenterol Hepatol. 2018 May;33(5):1115-1122. doi: 10.1111/jgh.14012. Epub 2018 Feb 6.

PMID:
28994147
16.

Utility of percutaneous radiofrequency ablation alone or combined with transarterial chemoembolization for early hepatocellular carcinoma.

Tamai T, Oshige A, Tabu K, Tabu E, Ijyuin S, Sakae H, Onishi H, Muromachi K, Saisyoji A, Oda K, Kumagai K, Mawatari S, Moriuchi A, Sakurai K, Hori T, Ido A.

Oncol Lett. 2017 Sep;14(3):3199-3206. doi: 10.3892/ol.2017.6476. Epub 2017 Jun 23.

17.

Human neutrophil peptide-1 promotes alcohol-induced hepatic fibrosis and hepatocyte apoptosis.

Ibusuki R, Uto H, Oda K, Ohshige A, Tabu K, Mawatari S, Kumagai K, Kanmura S, Tamai T, Moriuchi A, Tsubouchi H, Ido A.

PLoS One. 2017 Apr 12;12(4):e0174913. doi: 10.1371/journal.pone.0174913. eCollection 2017.

18.

Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.

Fujino T, Yamada T, Asada T, Tsuboi Y, Wakana C, Mawatari S, Kono S.

EBioMedicine. 2017 Mar;17:199-205. doi: 10.1016/j.ebiom.2017.02.012. Epub 2017 Feb 24.

19.

New resistance-associated substitutions and failure of dual oral therapy with daclatasvir and asunaprevir.

Mawatari S, Oda K, Tabu K, Ijuin S, Kumagai K, Inada Y, Uto H, Hiramine Y, Kure T, Fujisaki K, Hashiguchi M, Hori T, Oshige A, Imanaka D, Saishoji A, Taniyama O, Sakae H, Tamai T, Moriuchi A, Ido A.

J Gastroenterol. 2017 Jul;52(7):855-867. doi: 10.1007/s00535-016-1303-0. Epub 2017 Jan 11.

PMID:
28078469
20.

Silver Sulfadiazine-Impregnated Hydrocolloid Dressing Is Beneficial in Split-Thickness Skin-Graft Donor Wound Healing in a Small Randomized Controlled Study.

Akita S, Yoshimoto H, Tanaka K, Oishi M, Senju C, Mawatari S, Takahara E, Suzuki S, Hayashida K.

Int J Low Extrem Wounds. 2016 Dec;15(4):338-343. doi: 10.1177/1534734616670988. Epub 2016 Nov 29.

PMID:
27821789
21.

Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema.

Hiramine Y, Uto H, Imamura Y, Hiwaki T, Kure T, Ijuin S, Oda K, Mawatari S, Kumagai K, Tokunaga K, Higashi H, Kanetsuki I, Kubozono O, Maenohara S, Ido A.

Hepatol Res. 2017 May;47(6):542-557. doi: 10.1111/hepr.12778. Epub 2016 Aug 30.

PMID:
27448501
22.

Measurement of Ether Phospholipids in Human Plasma with HPLC-ELSD and LC/ESI-MS After Hydrolysis of Plasma with Phospholipase A1.

Mawatari S, Hazeyama S, Fujino T.

Lipids. 2016 Aug;51(8):997-1006. doi: 10.1007/s11745-016-4170-9. Epub 2016 Jul 7.

23.

Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice.

Kumagai K, Tabu K, Sasaki F, Takami Y, Morinaga Y, Mawatari S, Hashimoto S, Tanoue S, Kanmura S, Tamai T, Moriuchi A, Uto H, Tsubouchi H, Ido A.

PLoS One. 2015 Nov 23;10(11):e0143413. doi: 10.1371/journal.pone.0143413. eCollection 2015.

24.

Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis.

Yoshimine Y, Uto H, Kumagai K, Mawatari S, Arima S, Ibusuki R, Mera K, Nosaki T, Kanmura S, Numata M, Tamai T, Moriuchi A, Tsubouchi H, Ido A.

Oncol Rep. 2015 Apr;33(4):1657-66. doi: 10.3892/or.2015.3745. Epub 2015 Jan 21.

PMID:
25607821
25.

Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies.

Oda K, Uto H, Mawatari S, Ido A.

Clin J Gastroenterol. 2015 Feb;8(1):1-9. doi: 10.1007/s12328-014-0548-5. Epub 2015 Jan 10. Review.

PMID:
25575848
26.

Effect of endoscopic submucosal dissection for superficial esophageal neoplasms and risk factors for postoperative stricture.

Funakawa K, Uto H, Sasaki F, Nasu Y, Mawatari S, Arima S, Nakazawa J, Taguchi H, Hashimoto S, Kanmura S, Setoyama H, Numata M, Tsubouchi H, Ido A.

Medicine (Baltimore). 2015 Jan;94(1):e373. doi: 10.1097/MD.0000000000000373.

27.

Horizontal transmission of de novo hepatitis B between spouses: A case report.

Mawatari S, Uto H, Moriuchi A, Tabu K, Muromachi K, Tabu E, Oda K, Imanaka D, Oshige A, Nakazawa J, Kumagai K, Tamai T, Okamoto H, Tsubouchi H, Ido A.

Hepatol Res. 2015 Aug;45(8):933-938. doi: 10.1111/hepr.12422. Epub 2014 Oct 14.

PMID:
25211282
28.

Theoretical study of the structural stability of molecular chain sheet models of cellulose crystal allomorphs.

Uto T, Mawatari S, Yui T.

J Phys Chem B. 2014 Aug 7;118(31):9313-21. doi: 10.1021/jp503535d. Epub 2014 Jul 28.

PMID:
25050643
29.

Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C.

Mera K, Uto H, Mawatari S, Ido A, Yoshimine Y, Nosaki T, Oda K, Tabu K, Kumagai K, Tamai T, Moriuchi A, Oketani M, Shimada Y, Hidaka M, Eguchi S, Tsubouchi H.

BMC Gastroenterol. 2014 Feb 13;14:27. doi: 10.1186/1471-230X-14-27.

30.

Influence of human T-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis C virus infection.

Tokunaga M, Uto H, Oda K, Tokunaga M, Mawatari S, Kumagai K, Haraguchi K, Oketani M, Ido A, Ohnou N, Utsunomiya A, Tsubouchi H.

J Gastroenterol. 2014 Dec;49(12):1567-77. doi: 10.1007/s00535-013-0928-5. Epub 2014 Jan 25.

PMID:
24463696
31.

Hepatitis C virus NS3/4A protease inhibits complement activation by cleaving complement component 4.

Mawatari S, Uto H, Ido A, Nakashima K, Suzuki T, Kanmura S, Kumagai K, Oda K, Tabu K, Tamai T, Moriuchi A, Oketani M, Shimada Y, Sudoh M, Shoji I, Tsubouchi H.

PLoS One. 2013 Dec 12;8(12):e82094. doi: 10.1371/journal.pone.0082094. eCollection 2013.

32.

Dietary fructose enhances the incidence of precancerous hepatocytes induced by administration of diethylnitrosamine in rat.

Kumamoto R, Uto H, Oda K, Ibusuki R, Tanoue S, Arima S, Mawatari S, Kumagai K, Numata M, Tamai T, Moriuchi A, Fujita H, Oketani M, Ido A, Tsubouchi H.

Eur J Med Res. 2013 Dec 9;18:54. doi: 10.1186/2047-783X-18-54.

33.

Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats.

Arima S, Uto H, Ibusuki R, Kumamoto R, Tanoue S, Mawatari S, Oda K, Numata M, Fujita H, Oketani M, Ido A, Tsubouchi H.

Int J Mol Med. 2014 Jan;33(1):68-76. doi: 10.3892/ijmm.2013.1544. Epub 2013 Nov 1.

PMID:
24190226
34.

Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet.

Ibusuki R, Uto H, Arima S, Mawatari S, Setoguchi Y, Iwashita Y, Hashimoto S, Maeda T, Tanoue S, Kanmura S, Oketani M, Ido A, Tsubouchi H.

Liver Int. 2013 Nov;33(10):1549-56. doi: 10.1111/liv.12203. Epub 2013 May 20.

PMID:
23682724
35.

Gastric undifferentiated carcinoma with diffuse c-kit overexpression and focal neuroendocrine differentiation.

Mori D, Akashi M, Baba K, Morito K, Shibaki M, Hashimoto M, Nakamura A, Mawatari S, Sato S.

Pathol Res Pract. 2013 Feb 15;209(2):132-4. doi: 10.1016/j.prp.2012.12.004. Epub 2013 Jan 21.

PMID:
23347914
36.

Dietary plasmalogen increases erythrocyte membrane plasmalogen in rats.

Mawatari S, Katafuchi T, Miake K, Fujino T.

Lipids Health Dis. 2012 Nov 21;11:161. doi: 10.1186/1476-511X-11-161.

37.

Changes in phospholipid composition of erythrocyte membrane in Alzheimer's disease.

Oma S, Mawatari S, Saito K, Wakana C, Tsuboi Y, Yamada T, Fujino T.

Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):298-303. doi: 10.1159/000341603. Epub 2012 Aug 15.

38.

Anti-inflammatory/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinflammation in adult mice.

Ifuku M, Katafuchi T, Mawatari S, Noda M, Miake K, Sugiyama M, Fujino T.

J Neuroinflammation. 2012 Aug 13;9:197.

39.

Improvement of diabetic or obese patients' erythrocyte deformability by the program of the brain-oriented obesity control system (BOOCS).

Saito K, Odashiro K, Maruyama T, Akashi K, Mawatari S, Fujino T.

J Physiol Sci. 2012 Nov;62(6):445-51. doi: 10.1007/s12576-012-0221-z. Epub 2012 Jul 29.

PMID:
22843251
40.

Effects of plasmalogens on systemic lipopolysaccharide-induced glial activation and β-amyloid accumulation in adult mice.

Katafuchi T, Ifuku M, Mawatari S, Noda M, Miake K, Sugiyama M, Fujino T.

Ann N Y Acad Sci. 2012 Jul;1262:85-92. doi: 10.1111/j.1749-6632.2012.06641.x.

PMID:
22823439
41.

Difference in serum complement component C4a levels between hepatitis C virus carriers with persistently normal alanine aminotransferase levels or chronic hepatitis C.

Imakiire K, Uto H, Sato Y, Sasaki F, Mawatari S, Ido A, Shimoda K, Hayashi K, Stuver SO, Ito Y, Okanoue T, Tsubouchi H.

Mol Med Rep. 2012 Aug;6(2):259-64. doi: 10.3892/mmr.2012.924. Epub 2012 May 21.

42.

Clinical features of hepatitis C virus carriers with persistently normal alanine aminotransferase levels.

Uto H, Mawatari S, Kumagai K, Ido A, Tsubouchi H.

Hepat Mon. 2012 Feb;12(2):77-84. doi: 10.5812/hepatmon.829. Epub 2012 Feb 29.

43.

A new species of Hedgpethia (Arthropoda, Pycnogonida, Colossendeidae) from southwestern Japan.

Takahashi Y, Kajihara H, Mawatari SF.

Zookeys. 2012;(175):69-74. doi: 10.3897/zookeys.175.2612. Epub 2012 Mar 16.

44.

Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma.

Tamai T, Uto H, Takami Y, Oda K, Saishoji A, Hashiguchi M, Kumagai K, Kure T, Mawatari S, Moriuchi A, Oketani M, Ido A, Tsubouchi H.

World J Gastroenterol. 2011 Nov 28;17(44):4890-8. doi: 10.3748/wjg.v17.i44.4890.

45.

Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.

Oda K, Ido A, Tamai T, Matsushita M, Kumagai K, Mawatari S, Saishoji A, Kure T, Ohno K, Toyokura E, Imanaka D, Moriuchi A, Uto H, Oketani M, Hashiguchi T, Tsubouchi H.

Oncol Rep. 2011 Nov;26(5):1227-33. doi: 10.3892/or.2011.1425. Epub 2011 Aug 19.

PMID:
21874252
46.

Are plumatellid statoblasts in freshwater bryozoans phylogenetically informative?

Hirose M, Dick MH, Mawatari SF.

Zoolog Sci. 2011 May;28(5):318-26. doi: 10.2108/zsj.28.318.

47.

Cribrimorph and other Cauloramphus species (Bryozoa: Cheilostomata) from the Northwestern Pacific.

Dick MH, Mawatari SF, Sanner J, Grischenko AV.

Zoolog Sci. 2011 Feb;28(2):134-47. doi: 10.2108/ZSJ.28.134.

48.

Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period.

Hamabe A, Uto H, Imamura Y, Kusano K, Mawatari S, Kumagai K, Kure T, Tamai T, Moriuchi A, Sakiyama T, Oketani M, Ido A, Tsubouchi H.

J Gastroenterol. 2011 Jun;46(6):769-78. doi: 10.1007/s00535-011-0376-z. Epub 2011 Feb 8.

PMID:
21302121
49.

[Chronic liver disease and arteriosclerosis].

Mawatari S, Uto H, Tsubouchi H.

Nihon Rinsho. 2011 Jan;69(1):153-7. Review. Japanese.

PMID:
21226276
50.

Dietary sphingolipids ameliorate disorders of lipid metabolism in Zucker fatty rats.

Yunoki K, Renaguli M, Kinoshita M, Matsuyama H, Mawatari S, Fujino T, Kodama Y, Sugiyama M, Ohnishi M.

J Agric Food Chem. 2010 Jun 9;58(11):7030-5. doi: 10.1021/jf100722f.

PMID:
20443604

Supplemental Content

Loading ...
Support Center